Lisa M. Demeter - Concepedia

Author

Lisa M. Demeter

Also Known As

Bonaventura Clotet, Brian Conway, Crowe, Suzanne M, Eron, Joseph J., Hughes, Michael D., L M Demeter, L. Demeter, L. M. Demeter, L.M. Demeter, L. M. Demeter

Publications

7.7K

Citations

H-Index

Concepts

All Affiliations

University of Rochester Harvard University University of Miami University at Buffalo, State University of New York University of Alabama at Birmingham

About

Lisa M. Demeter is an author at University of Rochester specializing in medicine, hiv, and virology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	22	29	1.8K
2	Public Health	8	8	1.1K
3	Natural Sciences	5	5	173
4	Engineering	3	3	127
5	Health Sciences	1	1	18

Lisa M. Demeter

Publications

6.1K

Citations

H-Index

Page 1

	Year	Citations
A Controlled Trial of Two Nucleoside Analogues plus Indinavir in Persons with Human Immunodeficiency Virus Infection and CD4 Cell Counts of 200 per Cubic Millimeter or Less Scott M. Hammer, Kathleen Squires, Michael D. Hughes, New England Journal of Medicine	1997	2.7K
Antiretroviral Drug Resistance Testing in Adults Infected with Human Immunodeficiency Virus Type 1: 2003 Recommendations of an International AIDS Society–USA Panel Martin Hirsch, Françoise Brun‐Vézinet, Bonaventura Clotet, Clinical Infectious Diseases Primary ImmunodeficiencyType 1Sexual HealthHiv/aids CounsellingAdults Infected	2003	516
Worldwide Evaluation of DNA Sequencing Approaches for Identification of Drug Resistance Mutations in the Human Immunodeficiency Virus Type 1 Reverse Transcriptase Rob Schuurman, Lisa M. Demeter, Patricia Reichelderfer, Journal of Clinical Microbiology GeneticsGenetic EpidemiologyDna Sequencing ApproachesMolecular BiologyGenomics	1999	201
A Phase 1 Study of a Recombinant Viruslike Particle Vaccine against Human Papillomavirus Type 11 in Healthy Adult Volunteers Thomas G. Evans, William Bonnez, Robert C. Rose, The Journal of Infectious Diseases	2001	189
Production of human papillomavirus and modulation of the infectious program in epithelial raft cultures. OFF. Sheila C. Dollard, Jeffrey L. Wilson, Lisa M. Demeter, Genes & Development Collagen MatrixViral ReplicationViral PathogenesisPathologyCell Specialization	1992	186
Mutants of Human Immunodeficiency Virus Type 1 (HIV-1) Reverse Transcriptase Resistant to Nonnucleoside Reverse Transcriptase Inhibitors Demonstrate Altered Rates of RNase H Cleavage That Correlate with HIV-1 Replication Fitness in Cell Culture Richard Archer, Carrie Dykes, Peter Gerondelis, Journal of Virology	2000	101
Effects of Zidovudine Use During Pregnancy on Resistance and Vertical Transmission of Human Immunodeficiency Virus Type 1 Lisa M. Frenkel, Larry E. Wagner, Lisa M. Demeter, Clinical Infectious Diseases	1995	98
Prognostic Value of Plasma Human Immunodeficiency Virus Type 1 (HIV-l) RNA Levels in Patients with Advanced HIV-l Disease and with Little or No Prior Zidovudine Therapy Seth L. Welles, J. Brooks Jackson, Belinda Yen‐Lieberman, The Journal of Infectious Diseases	1996	93
Longitudinal Analysis of Quantitative Virologic Measures in Human Immunodeficiency Virus-Infected Subjects with >=400 CD4 Lymphocytes: Implications for Applying Measurements to Individual Patients William B. Paxton, Robert W. Coombs, M. Juliana McElrath, The Journal of Infectious Diseases	1997	89
Delavirdine Susceptibilities and Associated Reverse Transcriptase Mutations in Human Immunodeficiency Virus Type 1 Isolates from Patients in a Phase I/II Trial of Delavirdine Monotherapy (ACTG 260) Lisa M. Demeter, Robert W. Shafer, Patricia M. Meehan, Antimicrobial Agents and Chemotherapy	2000	86

Page 1